Currently, there is no licensed treatment and no standard of care for cancer cachexia. Putting this in the context of a condition which impairs the delivery of anti-cancer therapy (through increased side-effects, treatment delays, dose reductions) [1], causes marked distress to patients and their families and is associated with reduced survival, there remains an urgency to progress the research agenda in cancer cachexia [2].

中文翻译：

---

治疗癌症恶病质：不断发展的前景

当前，没有针对癌症恶病质的许可治疗和护理标准。将其置于会削弱抗癌治疗效果的情况下（通过增加副作用，治疗延迟，剂量减少）[1]，会给患者及其家人带来明显的困扰，并降低生存率。仍然迫切需要推进癌症恶病质的研究议程[2]。